| Literature DB >> 30208888 |
Xuemei Zhang1, Zhaowei Meng2, Xue Li1, Ming Liu3, Xiaojun Ren3, Mei Zhu3, Qing He3, Qing Zhang4, Kun Song4, Qiyu Jia4, Chunmei Zhang1, Xiaoran Wang1, Xiangxiang Liu1.
Abstract
OBJECTIVE: Dyslipidemia can cause some chronic diseases. Bilirubin is reported to have anti-inflammatory and anti-oxidant properties. We aimed to explore the relationship between triglyceride and total bilirubin (TB) in a large Chinese cohort.Entities:
Keywords: Age; Gender; Total bilirubin (TB); Triglyceride (TG)
Mesh:
Substances:
Year: 2018 PMID: 30208888 PMCID: PMC6136171 DOI: 10.1186/s12944-018-0857-7
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Participant characteristics
| Parameters | Males | Females | T value |
|---|---|---|---|
| Case number | 48,971 | 31,327 | |
| Age (years) | 46.57 ± 12.19 | 47.72 ± 13.13 | −12.661** |
| BMI (kg/m2) | 25.91 ± 3.22 | 24.00 ± 3.48 | 79.585** |
| SBP (mmHg) | 125.41 ± 16.05 | 121.35 ± 18.34 | 33.038** |
| DBP (mmHg) | 81.04 ± 11.08 | 74.82 ± 10.26 | 79.736** |
| ALT (U/L) | 27.02 ± 14.85 | 18.51 ± 10.70 | 87.929** |
| TB (μmol/L) | 13.69 ± 5.44 | 11.23 ± 4.53 | 66.494** |
| BUN (mmol/L) | 5.01 ± 1.24 | 4.43 ± 1.22 | 65.614** |
| Cr (μmol/L) | 79.29 ± 11.34 | 59.84 ± 9.58 | 251.494** |
| UA (μmol/L) | 362.23 ± 74.75 | 264.72 ± 59.84 | 194.452** |
| TG (mmol/L) | 1.81 ± 1.32 | 1.28 ± 0.87 | 62.513** |
| TC (mmol/L) | 5.13 ± 0.95 | 5.23 ± 1.03 | −15.311** |
| HDL (mmol/L) | 1.28 ± 0.31 | 1.56 ± 0.36 | − 117.095** |
| LDL (mmol/L) | 3.09 ± 0.83 | 3.11 ± 0.91 | −2.518** |
| G (mmol/L) | 3.34 ± 0.93 | 3.12 ± 0.91 | 31.524** |
BMI Body mass index, SBP Systolic blood pressure, DBP Diastolic blood pressure, ALT Alanine aminotransferase, TB Total bilirubin, BUN Blood urea nitrogen, Cr Creatinine, UA Uric acid, TG Triglycerides, TC Total cholesterol, HDL High-density lipoprotein, LDL Low-density lipoprotein, G Glucose
**P < 0.01 (analyzed by independent sample’s t test)
Participant characteristics of different age groups
| Parameters | Age ≤ 30 | 30 < age ≤ 60 | Age > 60 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| sex | male | female | F values | male | female | F values | male | female | F values |
| Case number | 5257 | 3609 | 37,755 | 22,527 | 5959 | 5191 | |||
| BMI (kg/m2) | 24.88 ± 3.76 | 21.46 ± 3.02 | 190.684** | 26.07 ± 3.14 | 24.02 ± 3.26 | 50.452** | 25.78 ± 3.01 | 25.66 ± 3.66 | 173.250** |
| SBP (mmHg) | 119.65 ± 11.83 | 109.77 ± 10.83 | 28.373** | 124.33 ± 15.29 | 118.97 ± 16.24 | 119.107** | 137.29 ± 18.30 | 139.72 ± 18.65 | 3.936* |
| DBP (mmHg) | 75.11 ± 9.01 | 69.38 ± 7.91 | 57.447** | 81.61 ± 11.16 | 74.79 ± 10.24 | 155.736** | 82.66 ± 10.64 | 78.76 ± 10.07 | 14.165** |
| ALT (U/L) | 27.68 ± 16.89 | 14.71 ± 8.45 | 1303.019** | 27.82 ± 14.94 | 18.79 ± 10.99 | 2083.180** | 21.43 ± 10.55 | 19.94 ± 10.21 | 6.966** |
| TB (μmol/L) | 14.24 ± 5.95 | 11.79 ± 5.22 | 60.727** | 13.60 ± 5.41 | 11.09 ± 4.49 | 707.774** | 13.80 ± 5.10 | 11.49 ± 4.15 | 181.755** |
| BUN (mmol/L) | 4.76 ± 1.15 | 3.95 ± 1.05 | 26.320** | 4.98 ± 1.20 | 4.35 ± 1.16 | 27.649** | 5.43 ± 1.38 | 5.08 ± 1.31 | 9.701** |
| Cr (μmol/L) | 79.27 ± 10.81 | 58.19 ± 8.89 | 125.779** | 78.97 ± 11.03 | 59.29 ± 8.90 | 875.220** | 81.32 ± 13.36 | 63.37 ± 11.81 | 82.126** |
| UA (μmol/L) | 368.08 ± 75.42 | 258.21 ± 53.95 | 312.995** | 363.60 ± 74.22 | 259.99 ± 57.42 | 1354.176** | 348.40 ± 75.92 | 289.78 ± 67.26 | 61.480** |
| TG (mmol/L) | 1.39 ± 1.03 | 0.85 ± 0.50 | 508.804** | 1.91 ± 1.40 | 1.27 ± 0.88 | 1688.890** | 1.58 ± 0.95 | 1.64 ± 0.89 | 0.624 |
| TC (mmol/L) | 4.71 ± 0.87 | 4.61 ± 0.82 | 20.302** | 5.17 ± 0.94 | 5.21 ± 1.00 | 84.977** | 5.19 ± 0.94 | 5.78 ± 1.04 | 41.255** |
| HDL (mmol/L) | 1.30 ± 0.30 | 1.62 ± 0.35 | 125.824** | 1.28 ± 0.31 | 1.56 ± 0.36 | 803.426** | 1.31 ± 0.32 | 1.53 ± 0.36 | 91.632** |
| LDL (mmol/L) | 2.81 ± 0.76 | 2.61 ± 0.73 | 17.376** | 3.11 ± 0.84 | 3.09 ± 0.88 | 58.622** | 3.19 ± 0.83 | 3.53 ± 0.93 | 50.946** |
| G (mmol/L) | 4.82 ± 0.57 | 4.67 ± 0.48 | 16.010** | 5.36 ± 1.28 | 5.02 ± 0.83 | 1047.438** | 5.73 ± 1.50 | 5.55 ± 1.36 | 35.448** |
BMI Body mass index, SBP Systolic blood pressure, DBP Diastolic blood pressure, ALT Alanine aminotransferase, TB Total bilirubin, BUN Blood urea nitrogen, Cr Creatinine, UA Uric acid, TG Triglycerides, TC Total cholesterol, HDL High-density lipoprotein, LDL Low-density lipoprotein, G Glucose
**P < 0.01 (analyzed by independent sample’s t test)
Pearson bivariate correlations between TG and other variables in different genders
| Parameters | Correlation coefficients for males | Correlation coefficients for females |
|---|---|---|
| Age | 0.027** | 0.311** |
| BMI | 0.244** | 0.320** |
| SBP | 0.116** | 0.298** |
| DBP | 0.171** | 0.245** |
| ALT | 0.245** | 0.225** |
| BUN | 0.009* | 0.078** |
| Cr | −0.008 | 0.073** |
| UA | 0.238** | 0.287** |
| TB | −0.099** | −0.073** |
| TC | 0.314** | 0.351** |
| HDL | −0.316** | −0.393** |
| LDL | 0.122** | 0.249** |
| G | 0.185** | 0.245** |
BMI Body mass index, SBP Systolic blood pressure, DBP Diastolic blood pressure, ALT Alanine aminotransferase, TB Total bilirubin, BUN Blood urea nitrogen, Cr Creatinine, UA Uric acid, TG Triglycerides, TC Total cholesterol, HDL High-density lipoprotein, LDL Low-density lipoprotein, G Glucose
* P < 0.05, ** P < 0.01
Fig. 1Incidence of high TG in different genders by TB quartiles. a: prevalence of all participants (male: TB ≤ 9.9 umol/L, 9.9 umol/L < TB ≤ 12.8 umol/L, 12.8 umol/L < TB ≤ 16.6 umol/L, TB ≥ 16.6 umol/L; female: TB ≤ 8.1 umol/L, 8.1 umol/L < TB ≤ 10.4 umol/L, 10.4 umol/L < TB ≤ 13.5 umol/L, TB ≥ 13.5 umol/L). The prevalence of participants in different age groups was also analyzed separately. (b: age ≤ 30, c: 30 < age ≤ 60, d: age > 60). * P < 0.05, ** P < 0.01
The risks of high TG according to TB quartiles in different genders
| TB Quartiles | Males | Females | ||
|---|---|---|---|---|
| Model 1 | TB values | Adjusted OR (CI)^ | TB values | Adjusted OR (CI)^ |
| TB Quartile 1 | TB < 9.90 (μmol/L, reference) | TB < 8.10 (μmol/L, reference) | ||
| TB Quartile 2 | 9.90 ≤ TB < 12.80 | 0.931 (0.832–1.041) | 8.10 ≤ TB < 10.40 | 0.948 (0.774–1.161) |
| TB Quartile 3 | 12.80 ≤ TB < 16.60 | 0.924 (0.825–1.036) | 10.40 ≤ TB < 13.50 | 0.857 (0.698–1.054) |
| TB Quartile 4 | TB ≥ 16.60 | 0.924 (0.823–1.038) | TB ≥ 13.50 | 0.935 (0.752–1.163) |
| Model 2 | 0.976 (0.972–0.979)** | 0.974 (0.968–0.980)** | ||
| Model 3 | 0.996 (0.989–1.004) | 0.991 (0.973–1.009) | ||
TB Total bilirubin, OR Odds ratio, CI Confidence interval
^Logistic regression model 1 with TB Quartile 1 as reference, including age, body mass index, blood pressure, alanine aminotransferase, blood urea nitrogen, creatinine, uric acid, total cholesterol, high-density lipoprotein, low-density lipoprotein and glucose as covariates
Model 2 and 3 analyzed TB as a continuous variable. Model 2 included TB as a covariate and model 3 included age, body mass index, blood pressure, alanine aminotransferase, blood urea nitrogen, creatinine, uric acid, total cholesterol, high-density lipoprotein, low-density lipoprotein and glucose as covariates
* P < 0.05, ** P < 0.01
The risks of high TG according to TB quartiles among people in different age groups
| TB quartile | Male | Female | ||
|---|---|---|---|---|
| TB values | Adjusted OR (CI)^ | TB values | Adjusted OR (CI)^ | |
| Age ≤ 30 | ||||
| TB Quartile 1 | TB < 10.0 (μmol/L, reference) | TB < 8.10 (μmol/L, reference) | ||
| TB Quartile 2 | 10.00 ≤ TB < 13.10 | 0.947 (0.847–1.060) | 8.10 ≤ TB < 10.80 | 2.047 (0.748–5.604) |
| TB Quartile 3 | 13.10 ≤ TB < 17.40 | 0.948 (0.846–1.062) | 10.80 ≤ TB < 14.40 | 1.072 (0.392–2.928) |
| TB Quartile 4 | TB ≥ 17.40 | 0.950 (0.846–1.065) | TB ≥ 14.40 | 1.105 (0.383–3.188) |
| Model 2 | 0.949 (0.938–0.961)** | 0.931 (0.896–0.967)** | ||
| Model 3 | 0.992 (0.960–1.024) | 0.986 (0.909–1.069) | ||
| 30 < age ≤ 60 | ||||
| TB Quartile 1 | TB < 9.80 (μmol/L, reference) | TB < 8.00 (μmol/L, reference) | ||
| TB Quartile 2 | 9.80 ≤ TB < 12.70 | 0.942 (0.834–1.065) | 8.00 ≤ TB < 10.30 | 0.894 (0.709–1.128) |
| TB Quartile 3 | 12.70 ≤ TB < 16.40 | 0.924 (0.816–1.046) | 10.30 ≤ TB < 13.30 | 0.856 (0.674–1.086) |
| TB Quartile 4 | TB ≥ 16.40 | 0.940 (0.829–1.066) | TB ≥ 13.30 | 0.876 (0.679–1.131) |
| Model 2 | 0.980 (0.976–0.984)** | 0.965 (0.958–0.973)** | ||
| Model 3 | 0.997 (0.989–1.006) | 0.986 (0.965–1.006) | ||
| Age > 60 | ||||
| TB Quartile 1 | TB < 10.20 (μmol/L, reference) | TB < 8.60 (μmol/L, reference) | ||
| TB Quartile 2 | 10.20 ≤ TB < 13.00 | 1.075 (0.737–1.567) | 8.60 ≤ TB < 10.70 | 1.046 (0.646–1.695) |
| TB Quartile 3 | 13.00 ≤ TB < 16.60 | 1.091 (0.741–1.607) | 10.70 ≤ TB < 13.60 | 0.883 (0.544–1.434) |
| TB Quartile 4 | TB ≥ 16.60 | 0.989 (0.669–1.461) | TB ≥ 13.60 | 1.139 (0.689–1.883) |
| Model 2 | 0.975 (0.964–0.985)** | 1.000 (0.987–1.014) | ||
| Model 3 | 0.999 (0.973–1.026) | 1.013 (0.974–1.054) | ||
TB Total bilirubin, OR Odds ratio, CI Confidence interval
^Logistic regression model 1 with TB Quartile 1 as reference, including age, body mass index, blood pressure, alanine aminotransferase, blood urea nitrogen, creatinine, uric acid, total cholesterol, high-density lipoprotein, low-density lipoprotein and glucose as covariates
Model 2 and 3 analyzed TB as a continuous variable. Model 2 included TB as a covariate and model 3 included age, body mass index, blood pressure, alanine aminotransferase, blood urea nitrogen, creatinine, uric acid, total cholesterol, high-density lipoprotein, low-density lipoprotein and glucose as covariates
* P < 0.05, ** P < 0.01